| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Luciferase | 9 | 0 | 0 | 9 |
| acetylcholinesterase | 11 | 0 | 0 | 11 |
| hypoxia-inducible factor 1 alpha subunit | 10 | 0 | 0 | 10 |
| RAR-related orphan receptor gamma | 23 | 0 | 0 | 23 |
| estrogen receptor 2 (ER beta) | 14 | 0 | 0 | 14 |
| progesterone receptor | 17 | 0 | 0 | 17 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 16 | 0 | 0 | 16 |
| EWS/FLI fusion protein | 11 | 0 | 0 | 11 |
| retinoic acid nuclear receptor alpha variant 1 | 22 | 0 | 0 | 22 |
| farnesoid X nuclear receptor | 12 | 0 | 0 | 12 |
| estrogen nuclear receptor alpha | 34 | 0 | 0 | 34 |
| G | 14 | 0 | 0 | 14 |
| cytochrome P450 2D6 | 11 | 0 | 0 | 11 |
| peroxisome proliferator-activated receptor delta | 15 | 0 | 0 | 15 |
| peroxisome proliferator activated receptor gamma | 18 | 0 | 0 | 18 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 19 | 0 | 0 | 19 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 7 | 0 | 0 | 7 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 12 | 0 | 0 | 12 |
| Histone H2A.x | 14 | 0 | 0 | 14 |
| heat shock protein beta-1 | 9 | 0 | 0 | 9 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 21 | 0 | 0 | 21 |
| Solute carrier family 22 member 1 | 0 | 5 | 0 | 5 |
| Solute carrier organic anion transporter family member 2B1 | 0 | 3 | 0 | 3 |
| Interferon beta | 17 | 0 | 0 | 17 |
| HLA class I histocompatibility antigen, B alpha chain | 14 | 0 | 0 | 14 |
| Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1ab | 0 | 1 | 1 | 2 |
| Thrombopoietin receptor | 0 | 0 | 1 | 1 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 8 | 0 | 8 |
| Sodium channel protein type 5 subunit alpha | 0 | 6 | 0 | 6 |
| Inositol hexakisphosphate kinase 1 | 14 | 0 | 0 | 14 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 5 | 0 | 6 |
| Potassium voltage-gated channel subfamily D member 3 | 0 | 1 | 0 | 1 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 6 | 1 | 9 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 6 | 0 | 6 |
| cytochrome P450 2C9, partial | 14 | 0 | 0 | 14 |
| Chain A, Ferritin light chain | 9 | 0 | 0 | 9 |
| acid sphingomyelinase | 3 | 0 | 0 | 3 |
| TDP1 protein | 25 | 0 | 0 | 25 |
| Smad3 | 3 | 0 | 0 | 3 |
| IDH1 | 8 | 0 | 0 | 8 |
| chromobox protein homolog 1 | 13 | 0 | 0 | 13 |
| NEDD8-activating enzyme E1 regulatory subunit isoform a | 0 | 1 | 0 | 1 |
| NEDD8-conjugating enzyme Ubc12 | 0 | 1 | 0 | 1 |
| nuclear receptor ROR-gamma isoform 1 | 12 | 0 | 0 | 12 |
| geminin | 25 | 0 | 0 | 25 |
| histone acetyltransferase KAT2A isoform 1 | 7 | 0 | 0 | 7 |
| ATP-binding cassette sub-family C member 3 | 0 | 16 | 0 | 16 |
| Multidrug resistance-associated protein 4 | 0 | 16 | 0 | 18 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 5 | 0 | 5 |
| Potassium channel subfamily K member 2 | 0 | 1 | 2 | 3 |
| Bile salt export pump | 0 | 23 | 0 | 23 |
| ATP-dependent translocase ABCB1 | 0 | 8 | 2 | 19 |
| Alpha-2A adrenergic receptor | 0 | 6 | 0 | 6 |
| Alpha-2C adrenergic receptor | 0 | 4 | 0 | 4 |
| Alpha-2B adrenergic receptor | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 5 | 0 | 5 |
| Alpha-2C adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-1D adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 6 | 0 | 2 | 0 | 2 |
| Spike glycoprotein | 10 | 0 | 0 | 10 |
| Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 8 | 0 | 9 |
| Potassium channel subfamily K member 2 | 0 | 2 | 0 | 2 |
| Canalicular multispecific organic anion transporter 1 | 0 | 17 | 0 | 18 |
| Chain A, HADH2 protein | 9 | 0 | 0 | 9 |
| Chain B, HADH2 protein | 9 | 0 | 0 | 9 |
| interleukin 8 | 5 | 0 | 0 | 5 |
| SMAD family member 2 | 6 | 0 | 0 | 6 |
| SMAD family member 3 | 6 | 0 | 0 | 6 |
| GLI family zinc finger 3 | 20 | 0 | 0 | 20 |
| AR protein | 29 | 0 | 0 | 29 |
| aldehyde dehydrogenase 1 family, member A1 | 16 | 0 | 0 | 16 |
| regulator of G-protein signaling 4 | 7 | 0 | 0 | 7 |
| nonstructural protein 1 | 4 | 0 | 0 | 4 |
| glucocorticoid receptor [Homo sapiens] | 25 | 0 | 0 | 25 |
| retinoid X nuclear receptor alpha | 20 | 0 | 0 | 20 |
| estrogen-related nuclear receptor alpha | 25 | 0 | 0 | 25 |
| pregnane X nuclear receptor | 21 | 0 | 0 | 21 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 17 | 0 | 0 | 17 |
| Caspase-7 | 5 | 0 | 0 | 5 |
| Bloom syndrome protein isoform 1 | 11 | 0 | 0 | 11 |
| peripheral myelin protein 22 isoform 1 | 6 | 0 | 0 | 6 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 8 | 0 | 0 | 8 |
| caspase-3 | 5 | 0 | 0 | 5 |
| thyroid hormone receptor beta isoform 2 | 21 | 0 | 0 | 21 |
| importin subunit beta-1 isoform 1 | 2 | 0 | 0 | 2 |
| mitogen-activated protein kinase 1 | 6 | 0 | 0 | 6 |
| nuclear factor NF-kappa-B p105 subunit isoform 1 | 1 | 0 | 0 | 1 |
| snurportin-1 | 2 | 0 | 0 | 2 |
| GTP-binding nuclear protein Ran isoform 1 | 1 | 0 | 0 | 1 |
| DNA polymerase iota isoform a (long) | 12 | 0 | 0 | 12 |
| peripheral myelin protein 22 | 12 | 0 | 0 | 12 |
| survival motor neuron protein isoform d | 7 | 0 | 0 | 7 |
| muscleblind-like protein 1 isoform 1 | 6 | 0 | 0 | 6 |
| lamin isoform A-delta10 | 16 | 0 | 0 | 16 |
| neuropeptide S receptor isoform A | 1 | 0 | 0 | 1 |
| Sex hormone-binding globulin | 0 | 1 | 3 | 4 |
| Beta-glucuronidase | 0 | 1 | 0 | 1 |
| Cholinesterase | 0 | 1 | 0 | 1 |
| Corticosteroid-binding globulin | 0 | 3 | 0 | 3 |
| Aromatase | 0 | 3 | 0 | 6 |
| Androgen receptor | 0 | 12 | 1 | 13 |
| Gastrin/cholecystokinin type B receptor | 0 | 0 | 0 | 1 |
| Testosterone 17-beta-dehydrogenase 3 | 0 | 2 | 0 | 2 |
| Alpha-synuclein | 2 | 3 | 0 | 5 |
| Nuclear receptor ROR-gamma | 7 | 1 | 1 | 9 |
| TAR DNA-binding protein 43 | 5 | 0 | 0 | 5 |
| Chain A, Hyaluronidase, phage associated | 0 | 1 | 0 | 1 |
| thioredoxin glutathione reductase | 4 | 0 | 0 | 4 |
| euchromatic histone-lysine N-methyltransferase 2 | 16 | 0 | 0 | 16 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 11 | 0 | 0 | 11 |
| lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
| lethal factor (plasmid) | 4 | 0 | 0 | 4 |
| Polyphenol oxidase 2 | 0 | 2 | 0 | 3 |
| Pancreatic alpha-amylase | 0 | 2 | 0 | 2 |
| Albumin | 0 | 1 | 0 | 1 |
| Urease | 0 | 1 | 0 | 1 |
| Prolyl 4-hydroxylase subunit alpha-1 | 0 | 0 | 0 | 1 |
| Tyrosinase | 0 | 1 | 0 | 1 |
| Alpha-2B adrenergic receptor | 0 | 4 | 1 | 5 |
| Hyaluronate lyase | 0 | 1 | 0 | 1 |
| Prolyl hydroxylase EGLN2 | 0 | 0 | 0 | 1 |
| Egl nine homolog 1 | 0 | 0 | 0 | 1 |
| Prolyl hydroxylase EGLN3 | 0 | 0 | 0 | 1 |
| Hypoxia-inducible factor 1-alpha inhibitor | 0 | 0 | 0 | 1 |
| Solute carrier family 23 member 1 | 0 | 1 | 0 | 1 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 10 | 0 | 0 | 10 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 7 | 0 | 0 | 7 |
| Chain A, Phospholipase A2 isoform 3 | 0 | 0 | 1 | 1 |
| Chain A, 2-oxoglutarate Oxygenase | 9 | 0 | 0 | 9 |
| GTP-binding protein (rab7) | 0 | 0 | 1 | 1 |
| ras protein, partial | 0 | 0 | 1 | 1 |
| thioredoxin reductase | 15 | 0 | 0 | 15 |
| GLS protein | 5 | 0 | 0 | 5 |
| thyroid stimulating hormone receptor | 7 | 0 | 0 | 7 |
| hypothetical protein, conserved | 2 | 0 | 0 | 2 |
| glucocerebrosidase | 4 | 0 | 0 | 4 |
| Rac1 protein | 0 | 0 | 1 | 1 |
| cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 1 | 1 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 7 | 0 | 0 | 7 |
| DNA polymerase kappa isoform 1 | 6 | 0 | 0 | 6 |
| muscarinic acetylcholine receptor M1 | 5 | 0 | 0 | 5 |
| Prostaglandin-H2 D-isomerase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 1 | 0 | 6 | 0 | 6 |
| Carbonic anhydrase 2 | 0 | 6 | 1 | 7 |
| Fatty acid-binding protein, liver | 0 | 2 | 0 | 2 |
| Integrin beta-3 | 3 | 1 | 0 | 4 |
| Myeloperoxidase | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 1 |
| Integrin alpha-IIb | 3 | 1 | 0 | 4 |
| Glutathione hydrolase 1 proenzyme | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 3 | 0 | 3 |
| Adenosine receptor A1 | 0 | 1 | 0 | 1 |
| Adenosine receptor A2a | 0 | 2 | 0 | 2 |
| Substance-P receptor | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 4 | 0 | 4 |
| Urotensin-2 receptor | 0 | 1 | 0 | 1 |
| 4-aminobutyrate aminotransferase, mitochondrial | 0 | 1 | 0 | 1 |
| Ras-related protein Rab-2A | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 9 | 2 | 0 | 11 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Rho-associated protein kinase 2 | 0 | 1 | 0 | 1 |
| Nicotinate phosphoribosyltransferase | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 20 | 0 | 3 | 0 | 3 |
| Solute carrier family 22 member 6 | 0 | 3 | 0 | 3 |
| Sigma non-opioid intracellular receptor 1 | 0 | 3 | 1 | 4 |
| Sigma non-opioid intracellular receptor 1 | 0 | 1 | 1 | 2 |
| phosphopantetheinyl transferase | 7 | 0 | 0 | 7 |
| ATAD5 protein, partial | 6 | 0 | 0 | 6 |
| Fumarate hydratase | 3 | 0 | 0 | 3 |
| Microtubule-associated protein tau | 11 | 0 | 0 | 11 |
| nuclear receptor subfamily 1, group I, member 3 | 18 | 0 | 0 | 18 |
| polyprotein | 3 | 0 | 0 | 3 |
| P53 | 1 | 0 | 0 | 1 |
| arylsulfatase A | 2 | 0 | 0 | 2 |
| aryl hydrocarbon receptor | 8 | 0 | 0 | 8 |
| thyroid stimulating hormone receptor | 13 | 0 | 0 | 13 |
| activating transcription factor 6 | 10 | 0 | 0 | 10 |
| hemoglobin subunit beta | 1 | 0 | 0 | 1 |
| cellular tumor antigen p53 isoform a | 4 | 0 | 0 | 4 |
| cytochrome P450 3A4 isoform 1 | 9 | 0 | 0 | 9 |
| M-phase phosphoprotein 8 | 4 | 0 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit pi | 9 | 1 | 0 | 10 |
| Bile salt export pump | 0 | 6 | 0 | 6 |
| Voltage-dependent calcium channel gamma-2 subunit | 14 | 0 | 0 | 14 |
| Cellular tumor antigen p53 | 17 | 0 | 0 | 17 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 9 | 1 | 0 | 10 |
| Gamma-aminobutyric acid receptor subunit delta | 9 | 1 | 0 | 10 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 9 | 1 | 0 | 10 |
| Glutamate receptor 2 | 14 | 1 | 0 | 15 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 9 | 1 | 0 | 10 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 9 | 1 | 0 | 10 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 9 | 1 | 0 | 10 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 9 | 1 | 0 | 10 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 9 | 1 | 0 | 10 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 9 | 1 | 0 | 10 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 9 | 1 | 0 | 10 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 9 | 1 | 0 | 10 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 9 | 1 | 0 | 10 |
| GABA theta subunit | 9 | 1 | 0 | 10 |
| ATPase family AAA domain-containing protein 5 | 10 | 0 | 0 | 10 |
| Ataxin-2 | 12 | 0 | 0 | 12 |
| Gamma-aminobutyric acid receptor subunit epsilon | 9 | 1 | 0 | 10 |
| Protein-arginine deiminase type-4 | 0 | 2 | 0 | 2 |
| endonuclease IV | 2 | 0 | 0 | 2 |
| glp-1 receptor, partial | 8 | 0 | 0 | 8 |
| USP1 protein, partial | 9 | 0 | 0 | 9 |
| 67.9K protein | 6 | 0 | 0 | 6 |
| LMP1 [Human herpesvirus 4] | 0 | 0 | 0 | 3 |
| thyroid hormone receptor beta isoform a | 6 | 0 | 0 | 6 |
| nuclear receptor coactivator 1 isoform 1 [Homo sapiens] | 0 | 3 | 0 | 3 |
| serine/threonine-protein kinase mTOR isoform 1 | 3 | 0 | 0 | 3 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 3 | 0 | 0 | 3 |
| transactivating tegument protein VP16 [Human herpesvirus 1] | 0 | 3 | 0 | 3 |
| nuclear receptor coactivator 3 isoform a | 0 | 3 | 0 | 3 |
| Thymidine kinase 2, mitochondrial | 0 | 1 | 0 | 1 |
| Thymidine kinase, cytosolic | 0 | 1 | 0 | 1 |
| Thymidine kinase | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 3 | 0 | 4 |
| Cytochrome P450 3A4 | 0 | 8 | 1 | 10 |
| Thymidine kinase | 0 | 1 | 0 | 1 |
| Deoxycytidine kinase | 0 | 0 | 0 | 1 |
| Probable deoxycytidylate deaminase | 0 | 0 | 0 | 1 |
| Cytidine deaminase | 0 | 1 | 0 | 2 |
| D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
| E3 ubiquitin-protein ligase Mdm2 | 0 | 1 | 0 | 1 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 1 | 0 | 1 |
| Thymidine kinase | 0 | 1 | 0 | 1 |
| Deoxynucleoside kinase | 0 | 1 | 0 | 1 |
| ATP-dependent phosphofructokinase | 6 | 0 | 0 | 6 |
| Chain A, Breast cancer type 1 susceptibility protein | 1 | 0 | 0 | 1 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 4 | 0 | 0 | 4 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 2 | 0 | 0 | 2 |
| PPM1D protein | 4 | 0 | 0 | 4 |
| caspase 7, apoptosis-related cysteine protease | 2 | 0 | 0 | 2 |
| caspase-3 | 2 | 0 | 0 | 2 |
| runt-related transcription factor 1 isoform AML1b | 1 | 0 | 0 | 1 |
| vitamin D3 receptor isoform VDRA | 9 | 0 | 0 | 9 |
| core-binding factor subunit beta isoform 2 | 1 | 0 | 0 | 1 |
| huntingtin isoform 2 | 3 | 0 | 0 | 3 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | 2 | 0 | 0 | 2 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 3 | 0 | 0 | 3 |
| Transthyretin | 0 | 1 | 0 | 1 |
| NADH-ubiquinone oxidoreductase chain 4 | 0 | 0 | 0 | 1 |
| 72 kDa type IV collagenase | 0 | 1 | 0 | 1 |
| DNA topoisomerase 2-alpha | 0 | 1 | 1 | 8 |
| Carbonyl reductase [NADPH] 1 | 0 | 0 | 0 | 1 |
| Glutamate receptor 1 | 1 | 1 | 0 | 2 |
| Glutamate receptor 3 | 1 | 1 | 0 | 2 |
| Glutamate receptor 4 | 1 | 1 | 0 | 2 |
| Platelet-activating factor receptor | 1 | 0 | 0 | 2 |
| Multidrug resistance-associated protein 1 | 0 | 4 | 1 | 8 |
| Histamine H2 receptor | 5 | 0 | 0 | 5 |
| Inositol monophosphatase 1 | 3 | 0 | 0 | 3 |
| Histone deacetylase 1 | 0 | 3 | 0 | 3 |
| Reverse transcriptase/RNaseH | 0 | 1 | 0 | 1 |
| Histone deacetylase 8 | 0 | 2 | 0 | 2 |
| Histone deacetylase 6 | 0 | 2 | 0 | 2 |
| Chain A, Sex Hormone-Binding Globulin | 0 | 0 | 1 | 1 |
| thyrotropin-releasing hormone receptor | 2 | 0 | 0 | 2 |
| transcriptional regulator ERG isoform 3 | 3 | 0 | 0 | 3 |
| Plasma kallikrein | 0 | 1 | 0 | 1 |
| Glucocorticoid receptor | 0 | 9 | 2 | 17 |
| Progesterone receptor | 0 | 1 | 0 | 1 |
| Progesterone receptor | 0 | 5 | 3 | 9 |
| Glucocorticoid receptor | 0 | 2 | 1 | 3 |
| Mineralocorticoid receptor | 0 | 3 | 1 | 4 |
| Sex hormone-binding globulin | 0 | 1 | 0 | 1 |
| Androgen receptor | 0 | 4 | 2 | 8 |
| Androgen receptor | 0 | 1 | 1 | 2 |
| Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
| Angiotensin-converting enzyme | 0 | 0 | 1 | 1 |
| Cannabinoid receptor 2 | 0 | 1 | 0 | 1 |
| G-protein coupled bile acid receptor 1 | 0 | 0 | 1 | 1 |
| Muscarinic acetylcholine receptor | 0 | 1 | 0 | 1 |
| Neuropeptide FF receptor 2 | 0 | 0 | 0 | 1 |
| ALK tyrosine kinase receptor | 0 | 1 | 0 | 1 |
| D(1A) dopamine receptor | 3 | 0 | 0 | 3 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 6 | 0 | 6 |
| Cytochrome P450 2C9 | 0 | 8 | 1 | 9 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 3 | 0 | 3 |
| Sodium channel protein type 1 subunit alpha | 0 | 4 | 0 | 4 |
| Sodium channel protein type 4 subunit alpha | 0 | 4 | 0 | 6 |
| 5-hydroxytryptamine receptor 7 | 0 | 3 | 0 | 3 |
| Cytochrome P450 2J2 | 0 | 6 | 0 | 6 |
| Sodium channel protein type 7 subunit alpha | 0 | 2 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 6 | 0 | 6 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 3 | 0 | 3 |
| Potassium voltage-gated channel subfamily A member 1 | 0 | 2 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 6 | 0 | 6 |
| Sodium channel protein type 9 subunit alpha | 0 | 4 | 0 | 4 |
| Sodium channel protein type 2 subunit alpha | 0 | 5 | 0 | 5 |
| Sodium channel protein type 3 subunit alpha | 0 | 5 | 0 | 5 |
| Sodium channel protein type 11 subunit alpha | 0 | 2 | 0 | 2 |
| Sodium channel protein type 8 subunit alpha | 0 | 2 | 0 | 2 |
| Sodium channel protein type 10 subunit alpha | 0 | 3 | 0 | 3 |
| urokinase-type plasminogen activator precursor | 3 | 0 | 0 | 3 |
| plasminogen precursor | 3 | 0 | 0 | 3 |
| urokinase plasminogen activator surface receptor precursor | 3 | 0 | 0 | 3 |
| Prothrombin | 0 | 0 | 0 | 1 |
| Regulatory protein E2 | 0 | 0 | 1 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
| DNA topoisomerase 1 | 0 | 1 | 0 | 2 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 2 | 0 | 2 |
| DNA topoisomerase 2 | 0 | 0 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 3 |
| UDP-glucuronosyltransferase 1A1 | 0 | 0 | 0 | 2 |
| Serum paraoxonase/arylesterase 1 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 0 | 0 | 1 |
| Caspase-3 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 0 | 0 | 1 |
| DNA topoisomerase 2-alpha | 0 | 0 | 0 | 1 |
| DNA topoisomerase 2-beta | 0 | 1 | 1 | 8 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 0 | 0 | 1 |
| Tubulin beta-2B chain | 0 | 1 | 0 | 1 |
| Integrase | 0 | 1 | 0 | 1 |
| Similar to alpha-tubulin isoform 1 | 0 | 1 | 0 | 1 |
| Similar to alpha-tubulin isoform 1 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 0 | 0 | 1 |
| Chain A, Dihydrofolate reductase | 0 | 0 | 1 | 1 |
| alpha-galactosidase | 2 | 0 | 0 | 2 |
| lysosomal alpha-glucosidase preproprotein | 3 | 0 | 0 | 3 |
| DNA polymerase beta | 3 | 0 | 0 | 3 |
| Thymidylate synthase | 0 | 4 | 0 | 4 |
| Dihydrofolate reductase | 0 | 4 | 3 | 7 |
| Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
| Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 4 |
| Solute carrier organic anion transporter family member 1A3 | 0 | 1 | 0 | 2 |
| Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 4 |
| Multidrug resistance associated protein | 0 | 1 | 0 | 3 |
| Glycogen synthase kinase-3 alpha | 0 | 1 | 0 | 1 |
| Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
| Protein cereblon | 0 | 4 | 0 | 4 |
| histone deacetylase 9 isoform 3 | 2 | 0 | 0 | 2 |
| Chain A, Cruzipain | 3 | 0 | 0 | 3 |
| Parkin | 3 | 0 | 0 | 3 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 3 | 0 | 0 | 3 |
| serine/threonine-protein kinase PLK1 | 2 | 0 | 0 | 2 |
| DNA polymerase eta isoform 1 | 2 | 0 | 0 | 2 |
| Ornithine decarboxylase | 0 | 0 | 0 | 2 |
| Adenosine receptor A3 | 0 | 6 | 0 | 6 |
| Retinoic acid receptor alpha | 0 | 2 | 2 | 4 |
| Alpha-1B adrenergic receptor | 0 | 6 | 0 | 6 |
| Retinoic acid receptor gamma | 0 | 2 | 2 | 4 |
| Retinoic acid receptor beta | 0 | 2 | 2 | 4 |
| Cellular retinoic acid-binding protein 2 | 0 | 0 | 2 | 2 |
| Mitogen-activated protein kinase 1 | 0 | 3 | 0 | 3 |
| Retinoic acid receptor RXR-alpha | 0 | 2 | 2 | 4 |
| Retinoic acid receptor RXR-beta | 0 | 2 | 2 | 4 |
| Retinoic acid receptor RXR-gamma | 0 | 2 | 2 | 4 |
| Cellular retinoic acid-binding protein 1 | 0 | 2 | 0 | 3 |
| 5-hydroxytryptamine receptor 2B | 0 | 6 | 0 | 6 |
| Alpha-1A adrenergic receptor | 0 | 6 | 0 | 6 |
| Cellular retinoic acid-binding protein 1 | 0 | 0 | 2 | 2 |
| Mitogen-activated protein kinase 14 | 0 | 1 | 0 | 1 |
| Rap guanine nucleotide exchange factor 4 | 1 | 0 | 0 | 1 |
| Olfactory receptor 51E2 | 0 | 1 | 0 | 1 |
| GALC protein | 2 | 0 | 0 | 2 |
| cytochrome P450 2D6 isoform 1 | 3 | 0 | 0 | 3 |
| Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 2 subunit alpha | 0 | 2 | 0 | 2 |
| Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily E member 1 | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily KQT member 1 | 0 | 1 | 0 | 1 |
| cystic fibrosis transmembrane conductance regulator ATP-binding cassette sub-family C member 7 | 0 | 0 | 0 | 1 |
| Estrogen receptor | 0 | 6 | 0 | 6 |
| Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
| Cannabinoid receptor 1 | 0 | 2 | 0 | 2 |
| Sodium-dependent noradrenaline transporter | 0 | 2 | 0 | 2 |
| Sodium-dependent serotonin transporter | 0 | 6 | 0 | 6 |
| Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
| Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
| Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
| dopamine D1 receptor | 1 | 0 | 0 | 1 |
| ClpP | 1 | 0 | 0 | 1 |
| 15-lipoxygenase, partial | 2 | 0 | 0 | 2 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | 2 | 0 | 0 | 2 |
| flap endonuclease 1 | 2 | 0 | 0 | 2 |
| caspase-1 isoform alpha precursor | 1 | 0 | 0 | 1 |
| Toll-like receptor 4 | 0 | 1 | 0 | 1 |
| Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
| ATP-binding cassette sub-family C member 3 | 0 | 1 | 0 | 2 |
| Dihydrofolate reductase | 0 | 2 | 0 | 3 |
| Dihydrofolate reductase | 0 | 2 | 0 | 3 |
| Dihydrofolate reductase | 0 | 2 | 0 | 2 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 3 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase ABL1 | 0 | 0 | 1 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2C | 0 | 1 | 0 | 2 |
| High mobility group protein B1 | 0 | 0 | 2 | 2 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Folate receptor beta | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 3 | 0 | 3 |
| Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
| Folate receptor alpha | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 2 |
| Histidine decarboxylase | 0 | 1 | 0 | 1 |
| Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 2 | 0 | 0 | 1 | 1 |
| Bifunctional purine biosynthesis protein ATIC | 0 | 3 | 0 | 3 |
| Delta-type opioid receptor | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 3 | 0 | 3 |
| Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
| Reduced folate transporter | 0 | 2 | 0 | 2 |
| 6-phosphogluconate dehydrogenase, decarboxylating | 0 | 1 | 0 | 1 |
| Caspase-7 | 1 | 0 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Pteridine reductase 1 | 0 | 1 | 0 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 2 |
| Canalicular multispecific organic anion transporter 1 | 0 | 1 | 0 | 2 |
| Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 1 | 0 | 2 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| ATP-binding cassette sub-family C member 11 | 0 | 0 | 0 | 1 |
| Proton-coupled folate transporter | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 11 | 0 | 0 | 0 | 1 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 6 | 0 | 0 | 6 |
| bromodomain adjacent to zinc finger domain 2B | 3 | 0 | 0 | 3 |
| nuclear receptor subfamily 1, group I, member 2 | 2 | 0 | 0 | 2 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 2 | 2 |
| Glycine receptor subunit alpha-1 | 0 | 8 | 0 | 8 |
| Glycine receptor subunit beta | 0 | 8 | 0 | 8 |
| Glycine receptor subunit alpha-2 | 0 | 8 | 0 | 8 |
| Glycine receptor subunit alpha-3 | 0 | 8 | 0 | 8 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
| Thioredoxin reductase | 0 | 1 | 0 | 1 |
| Flavodoxin | 0 | 0 | 0 | 1 |
| Lanosterol 14-alpha demethylase | 0 | 1 | 0 | 1 |
| Histone deacetylase 3 | 0 | 2 | 0 | 2 |
| Nuclear receptor corepressor 1 | 0 | 1 | 0 | 1 |
| Integrin beta-1 | 0 | 1 | 0 | 1 |
| Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| Cytochrome P450 2D6 | 0 | 2 | 1 | 3 |
| Integrin alpha-4 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C19 | 0 | 3 | 1 | 4 |
| Histone deacetylase 4 | 0 | 1 | 0 | 1 |
| Histone deacetylase 7 | 0 | 1 | 0 | 1 |
| Histone deacetylase 2 | 0 | 2 | 0 | 2 |
| Histone deacetylase 11 | 0 | 1 | 0 | 1 |
| Histone deacetylase 5 | 0 | 1 | 0 | 1 |
| Nuclear receptor corepressor 2 | 0 | 1 | 0 | 1 |
| Chain A, Inosine-5'-Monophosphate Dehydrogenase 2 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1A9 | 0 | 0 | 0 | 1 |
| Inosine-5'-monophosphate dehydrogenase 2 | 0 | 2 | 0 | 2 |
| Inosine-5'-monophosphate dehydrogenase 1 | 0 | 2 | 0 | 2 |
| Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
| Peroxisome proliferator-activated receptor gamma | 0 | 0 | 1 | 1 |
| Inosine-5'-monophosphate dehydrogenase | 0 | 1 | 0 | 2 |
| UDP-glucuronosyltransferase 1A7 | 0 | 0 | 0 | 1 |
| UDP-glucuronosyltransferase 1A10 | 0 | 0 | 0 | 1 |
| UDP-glucuronosyltransferase 1A8 | 0 | 0 | 0 | 1 |
| Chain A, Beta-lactamase | 3 | 0 | 0 | 3 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 2 | 0 | 0 | 2 |
| pregnane X receptor | 4 | 0 | 0 | 4 |
| NFKB1 protein, partial | 1 | 0 | 0 | 1 |
| Thrombopoietin | 1 | 0 | 0 | 1 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
| beta-2 adrenergic receptor | 2 | 0 | 0 | 2 |
| tumor necrosis factor | 1 | 0 | 0 | 1 |
| cytochrome P450 2C19 precursor | 2 | 0 | 0 | 2 |
| cytochrome P450 2C9 precursor | 3 | 0 | 0 | 3 |
| perilipin-5 | 0 | 1 | 0 | 1 |
| perilipin-1 | 0 | 1 | 0 | 1 |
| atrial natriuretic peptide receptor 2 precursor | 1 | 0 | 0 | 1 |
| eyes absent homolog 2 isoform a | 1 | 0 | 0 | 1 |
| 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 4 | 0 | 4 |
| Glutathione reductase, mitochondrial | 0 | 2 | 0 | 2 |
| Cytochrome P450 1A2 | 0 | 1 | 1 | 2 |
| Muscarinic acetylcholine receptor M2 | 0 | 0 | 0 | 1 |
| Muscarinic acetylcholine receptor M4 | 0 | 0 | 0 | 1 |
| Muscarinic acetylcholine receptor M5 | 0 | 0 | 0 | 1 |
| Muscarinic acetylcholine receptor M1 | 0 | 0 | 0 | 1 |
| Phospholipase A2, membrane associated | 0 | 0 | 0 | 1 |
| Muscarinic acetylcholine receptor M3 | 0 | 0 | 0 | 1 |
| Potassium voltage-gated channel subfamily A member 5 | 0 | 1 | 0 | 1 |
| 3-oxo-5-alpha-steroid 4-dehydrogenase 1 | 0 | 1 | 0 | 1 |
| Thromboxane-A synthase | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2C | 0 | 4 | 0 | 4 |
| Indoleamine 2,3-dioxygenase 1 | 0 | 2 | 0 | 2 |
| Adenosine receptor A2a | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 2 | 0 | 2 |
| 3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 1 | 0 | 1 |
| C-C chemokine receptor type 2 | 0 | 2 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
| C-terminal-binding protein 1 | 1 | 0 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
| Leukotriene B4 receptor 1 | 0 | 0 | 0 | 1 |
| Myosin light chain kinase, smooth muscle | 0 | 1 | 0 | 1 |
| Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
| Beta-2 adrenergic receptor | 0 | 0 | 0 | 1 |
| Indoleamine 2,3-dioxygenase 2 | 0 | 2 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
| Leukotriene B4 receptor 2 | 0 | 0 | 0 | 1 |
| Estrogen receptor | 0 | 0 | 1 | 1 |
| Estrogen receptor beta | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 1A | 0 | 5 | 0 | 5 |
| mu-type opioid receptor isoform MOR-1 | 0 | 0 | 1 | 1 |
| Vpr | 1 | 0 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 0 | 1 | 1 |
| Neuronal acetylcholine receptor subunit alpha-4 | 1 | 0 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-2 | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid | 0 | 1 | 0 | 1 |
| atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit epsilon | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 0 | 1 |
| luciferase | 0 | 0 | 0 | 1 |
| Glucocorticoid receptor | 0 | 0 | 1 | 1 |
| Glutamine synthetase | 0 | 0 | 1 | 1 |
| Histamine H1 receptor | 0 | 0 | 1 | 1 |
| Nociceptin receptor | 0 | 0 | 1 | 1 |
| Estrogen receptor beta | 0 | 2 | 0 | 2 |
| Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
| Chain A, PLASMA RETINOL-BINDING PROTEIN PRECURSOR | 0 | 0 | 1 | 1 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 3 | 0 | 0 | 3 |
| Retinol-binding protein 4 | 0 | 0 | 1 | 1 |
| Beta-lactoglobulin | 0 | 0 | 1 | 1 |
| Amyloid-beta precursor protein | 0 | 2 | 0 | 2 |
| Disintegrin and metalloproteinase domain-containing protein 17 | 3 | 0 | 0 | 3 |
| chaperonin-containing TCP-1 beta subunit homolog | 1 | 0 | 0 | 1 |
| Estrogen receptor beta | 0 | 0 | 0 | 1 |
| Inhibitor of nuclear factor kappa-B kinase subunit beta | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 12 | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit beta-2 | 0 | 0 | 0 | 1 |
| Albumin | 0 | 1 | 1 | 2 |
| Polymerase acidic protein | 0 | 0 | 1 | 1 |
| Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
| Stromelysin-1 | 0 | 0 | 1 | 1 |
| Tyrosine-protein phosphatase YopH | 0 | 1 | 0 | 1 |
| Prolyl 4-hydroxylase subunit alpha-1 | 0 | 1 | 0 | 1 |
| Tyrosine-protein phosphatase non-receptor type 1 | 0 | 1 | 0 | 3 |
| Estrogen receptor | 0 | 0 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 4 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 6 | 0 | 1 | 0 | 1 |
| Cystathionine gamma-lyase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 7 | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-1 | 0 | 0 | 0 | 1 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-2 | 0 | 0 | 0 | 1 |
| Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-1 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 9 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
| Ubiquitin-like domain-containing CTD phosphatase 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 15 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-3 | 0 | 0 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-2 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 14 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit beta-1 | 0 | 0 | 0 | 1 |
| Chain A, Glutathione S-transferase | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
| Tumor necrosis factor | 0 | 0 | 1 | 1 |
| Interstitial collagenase | 0 | 1 | 0 | 1 |
| Fibroblast growth factor 1 | 0 | 0 | 1 | 1 |
| Caspase-1 | 0 | 1 | 0 | 1 |
| Flavin reductase (NADPH) | 0 | 0 | 1 | 1 |
| Sodium/bile acid cotransporter | 0 | 1 | 0 | 1 |
| Cystine/glutamate transporter | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 2B7 | 0 | 0 | 0 | 1 |
| Cytochrome P450 3A5 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1A4 | 0 | 0 | 0 | 1 |
| Serine/threonine-protein kinase mTOR | 0 | 1 | 0 | 1 |
| Peptidyl-prolyl cis-trans isomerase FKBP1A | 0 | 2 | 1 | 3 |
| Peptidyl-prolyl cis-trans isomerase FKBP1B | 0 | 0 | 1 | 1 |
| Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | 0 | 1 | 0 | 1 |
| Peptidyl-prolyl cis-trans isomerase FKBP5 | 0 | 1 | 0 | 1 |
| Splicing factor 3B subunit 3 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C8 | 0 | 2 | 0 | 2 |
| Cytochrome P450 2B6 | 0 | 2 | 0 | 2 |
| Chain A, Nuclear Receptor ROR-beta | 0 | 1 | 0 | 1 |
| Ornithine decarboxylase | 0 | 0 | 0 | 1 |
| 60 kDa chaperonin | 0 | 1 | 0 | 1 |
| Retinoic acid receptor alpha | 0 | 2 | 2 | 7 |
| 60 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
| Retinoic acid receptor beta | 0 | 2 | 2 | 7 |
| Retinoic acid receptor gamma | 0 | 2 | 2 | 7 |
| Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
| Retinoic acid receptor RXR-alpha | 0 | 2 | 2 | 4 |
| Alpha-1D adrenergic receptor | 0 | 1 | 0 | 1 |
| Retinoic acid receptor RXR-beta | 0 | 2 | 2 | 4 |
| Nuclear receptor ROR-alpha | 0 | 1 | 0 | 1 |
| Retinoic acid receptor RXR-gamma | 0 | 2 | 2 | 4 |
| 10 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
| Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 0 | 2 | 1 | 3 |
| Thiosulfate sulfurtransferase | 0 | 1 | 0 | 1 |
| 60 kDa chaperonin | 0 | 1 | 0 | 1 |
| 10 kDa chaperonin | 0 | 1 | 0 | 1 |
| Nuclear receptor ROR-beta | 0 | 1 | 0 | 1 |
| Chain A, Uracil-DNA Glycosylase | 0 | 1 | 0 | 1 |
| Glycoprotein | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M2 | 0 | 0 | 1 | 1 |
| Catechol O-methyltransferase | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily A member 3 | 0 | 1 | 0 | 1 |
| Histamine H2 receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1B | 0 | 2 | 0 | 2 |
| Delta-type opioid receptor | 0 | 1 | 0 | 1 |
| D(3) dopamine receptor | 0 | 2 | 0 | 2 |
| Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
| D(2) dopamine receptor | 0 | 1 | 0 | 1 |
| Chloroquine resistance transporter | 0 | 1 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |